CH527207A - Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen - Google Patents

Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen

Info

Publication number
CH527207A
CH527207A CH619669A CH619669A CH527207A CH 527207 A CH527207 A CH 527207A CH 619669 A CH619669 A CH 619669A CH 619669 A CH619669 A CH 619669A CH 527207 A CH527207 A CH 527207A
Authority
CH
Switzerland
Prior art keywords
azacytosines
glycosyl
preparation
Prior art date
Application number
CH619669A
Other languages
English (en)
Inventor
Sorm Frantisek
Piskala Alois
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of CH527207A publication Critical patent/CH527207A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH619669A 1968-05-08 1969-04-23 Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen CH527207A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS339968 1968-05-08

Publications (1)

Publication Number Publication Date
CH527207A true CH527207A (de) 1972-08-31

Family

ID=5373920

Family Applications (1)

Application Number Title Priority Date Filing Date
CH619669A CH527207A (de) 1968-05-08 1969-04-23 Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen

Country Status (12)

Country Link
JP (1) JPS4916435B1 (de)
AT (1) AT306930B (de)
BE (1) BE732268A (de)
BR (1) BR6908600D0 (de)
CA (1) CA921904A (de)
CH (1) CH527207A (de)
DE (1) DE1922702A1 (de)
ES (1) ES366910A1 (de)
FR (1) FR2008048A1 (de)
GB (1) GB1227691A (de)
IT (1) IT1037009B (de)
NL (1) NL6906909A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2012888C3 (de) * 1970-03-14 1981-04-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden
US6905669B2 (en) 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
WO2008044041A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
HUE055911T2 (hu) 2008-05-15 2021-12-28 Celgene Corp Citidin-analógokat tartalmazó orális készítmények, és eljárások azok alkalmazására
AU2009279461B2 (en) 2008-08-08 2014-01-23 Scinopharm Taiwan, Ltd. Process for making 5-azacytosine nucleosides and their derivatives
JP6289361B2 (ja) 2011-03-31 2018-03-07 セルジーン インターナショナル サルル ５−アザシチジンの合成
PH12018501678B1 (en) 2011-08-30 2022-08-10 Astex Pharmaceuticals Inc Decitabine derivative formulations
EP3316685A4 (de) 2015-07-02 2019-03-13 Otsuka Pharmaceutical Co., Ltd. Lyophilisierte pharmazeutische zusammensetzungen
WO2017090264A1 (ja) 2015-11-27 2017-06-01 大原薬品工業株式会社 ５－アザシチジン又は其の２'－デオキシ体の５'位ジベンジル燐酸エステル
WO2017183215A1 (ja) 2016-04-21 2017-10-26 大原薬品工業株式会社 ５－アザシチジン類の糖部シリルエーテル誘導体
US10227374B2 (en) 2016-04-21 2019-03-12 Ohara Pharmaceutical Co., Ltd. Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
EP3661522A2 (de) 2017-08-03 2020-06-10 Otsuka Pharmaceutical Co., Ltd. Arzneimittelverbindung und reinigungsverfahren dafür
US20220332737A1 (en) * 2019-06-07 2022-10-20 Ludwig-Maximilians-Universität München Carbocyclic nucleoside analogue

Also Published As

Publication number Publication date
GB1227691A (de) 1971-04-07
FR2008048A1 (de) 1970-01-16
BE732268A (de) 1969-10-01
CA921904A (en) 1973-02-27
JPS4916435B1 (de) 1974-04-22
IT1037009B (it) 1979-11-10
DE1922702A1 (de) 1969-11-20
BR6908600D0 (pt) 1973-02-22
AT306930B (de) 1973-04-25
ES366910A1 (es) 1971-03-16
NL6906909A (de) 1969-11-11

Similar Documents

Publication Publication Date Title
CH507249A (de) Verfahren zur Herstellung von 2-Brom-a-ergokryptin
AT306930B (de) Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen
AT291254B (de) Verfahren zur herstellung von 3-amino-4jod-5-methyllisoxazolen
CH519453A (de) Verfahren zur Herstellung von Dihalogenphenolen
AT296964B (de) Verfahren zur Herstellung von 1-Hydroxyphenyl-2-aminoäthanolen
CH501573A (de) Verfahren zur Herstellung von Trimethyl-p-benzochinon
AT295757B (de) Verfahren zur Herstellung von Benzindenen
AT294064B (de) Verfahren zur Herstellung von 1-Alkyl-2-aminomethylpyrrolidinen
CH516529A (de) Verfahren zur Herstellung von 4-Cyano-4-phenyl-aminocyclohexanen
CH520135A (de) Verfahren zur Herstellung von Erythromycylamin
AT296254B (de) Verfahren zur Herstellung von 2-Acyloxythionobenzamiden
CH513141A (de) Verfahren zur Herstellung von Glyoxaldithiosemicarbazonen
CH520672A (de) Verfahren zur Herstellung von Chlorfluorpyridinen
CH519509A (de) Verfahren zur Herstellung von Thiophen-3-isonitrilen
AT286252B (de) Verfahren zur Herstellung von 3-Aminopropanolen
AT314097B (de) Verfahren zur Herstellung von 19-Norsteroiden
CH507969A (de) Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
CH517081A (de) Verfahren zur Herstellung von a-Oximinoketonen
AT289737B (de) Verfahren zur Herstellung von Sulfatobetainen
CH505089A (de) Verfahren zur Herstellung von 3-substituierten-7-Aminocumarinen
CH517703A (de) Verfahren zur Herstellung von Glycyl-L-tryptophyl-L-methionyl-glycinamiden
CH517758A (de) Verfahren zur Herstellung von 1-Pyridyl-2-imidazolonen
CH518290A (de) Verfahren zur Herstellung von Hydroxyphenazin-di-N-oxiden
AT291577B (de) Verfahren zur Herstellung von Polyacyloxamidrazonen
CH484975A (de) Verfahren zur Herstellung von Polyacyloxamidrazonen

Legal Events

Date Code Title Description
PL Patent ceased